Talus Bio is a drug discovery biotech startup working on drug development for gene regulators.
Talus Bio is a drug discovery biotech startup working on drug development for gene regulators. The company is building a data-enabled platform that focuses primarily on small molecule drug development in oncology.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 6, 2022 | Grant | $2.75M | 1 | National Institutes of Health | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |